Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols.

Authors :: Redfors B
Source :: Scandinavian cardiovascular journal : SCJ [Scand Cardiovasc J] 2024 Dec; Vol. 58 (1), pp. 2343383. Date of Electronic Publication: 2024 May 02.
Publication Year :: 2024

Subjects :: Humans
Health Care Costs legislation & jurisprudence
Treatment Outcome
Prospective Studies
Patient Safety
Cost-Benefit Analysis
Registries
Cardiovascular Diseases economics
Cardiovascular Diseases diagnosis
Cardiovascular Diseases therapy

Full Text Access

Tools